BioLineRx Ltd. (BLRX) stock
BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15+0.03 (+2.68%)
Close on Nov 18, 2026Market cap $5.00MP/E –Yield –
BioLineRx free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$8.10M. The highest annual figure on record is -$8.10M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.10M | – |
| FY2024 | Dec 31, 2024 | -$43.93M | – |
| FY2023 | Dec 31, 2023 | -$22.72M | – |
| FY2022 | Dec 31, 2022 | -$26.37M | – |
| FY2021 | Dec 31, 2021 | -$23.67M | – |
| FY2020 | Dec 31, 2020 | -$23.21M | – |
| FY2019 | Dec 31, 2019 | -$22.73M | – |
| FY2018 | Dec 31, 2018 | -$24.37M | – |
| FY2017 | Dec 31, 2017 | -$20.89M | – |
| FY2016 | Dec 31, 2016 | -$14.57M | – |
| FY2015 | Dec 31, 2015 | -$16.85M | – |
See a number that looks wrong?